← FDA Drug Approvals (Drugs@FDA)

LOPINAVIR AND RITONAVIR

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LANNETT CO INC · Approved 2016-12-27

Drug application

FDA Application #

ANDA207407

Application type

Abbreviated New Drug Application (Generic)

Brand name

LOPINAVIR AND RITONAVIR

Generic name

Lopinavir

Active ingredients

LOPINAVIR; RITONAVIR

Dosage form

SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

LANNETT CO INC

First approval

2016-12-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown